| Literature DB >> 26672058 |
Nicky Pieters1, Bram G Janssen, Harrie Dewitte, Bianca Cox, Ann Cuypers, Wouter Lefebvre, Karen Smeets, Charlotte Vanpoucke, Michelle Plusquin, Tim S Nawrot.
Abstract
BACKGROUND: Telomere length and mitochondrial DNA (mtDNA) content are markers of aging and aging-related diseases. There is inconclusive evidence concerning the mechanistic effects of airborne particulate matter (PM) exposure on biomolecular markers of aging.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26672058 PMCID: PMC4937852 DOI: 10.1289/ehp.1509728
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Assay information of the selected candidate genes.
| Abbreviation | IDT assay | Gene name | Ref seq number | Primer efficiency (%) | Exon location | Amplicon length (bp) |
|---|---|---|---|---|---|---|
| Hs.PT.39a.22214821 | Hypoxanthine phosphoribosyltransferase 1 | NM_000194 | 93 | 6–8 | 128 | |
| Hs.PT.56a.3666627 | Nuclear respiratory factor 1 | NM_005011 | 106 | 12–13 | 102 | |
| Hs.PT.56a.40946676.gs | Nuclear factor erythroid 2-like 2 | NM_006164 | 99 | 4–5 | 124 | |
| Hs.PT.56a.40982761 | Peroxisome proliferator-activated receptor γ, coactivator 1 α | NM_013261 | 99 | 12–13 | 133 | |
| Hs.PT.56a.38577994 | Peroxisome proliferator-activated receptor γ, coactivator 1 β | NM_133263 | 105 | 12–13 | 102 | |
| Hs.PT.56a.40434846 | Acidic ribosomal phosphoprotein P0 | NM_053275 | 101 | 7–8 | 146 | |
| Hs.PT.56a.40870995 | Sirtuin 1 | NM_001142498 | 94 | 9–10 | 133 | |
| Hs.PT.56a.39489752.g | Tumor protein p53 | NM_001126114 | 90 | 16–16 | 146 | |
| YWHAZ | Hs.PT.39a.22214858 | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | NM_003406 | 106 | 1–2 | 135 |
| bp, base pairs; IDT, integrated DNA technologies. | ||||||
Characteristics of the study population, stratified by sex.
| Characteristics | Men ( | Women ( |
|---|---|---|
| Age (years) | 70.2 ± 5.1 | 70.8 ± 4.3 |
| BMI (kg/m2) | 27.5 ± 3.7 | 27.3 ± 5.1 |
| Former smoker | 58 (76%) | 31 (35%) |
| Pack years | 19.0 ± 17.7 | 13.3 ± 12.5 |
| Socioeconomic status | ||
| Low | 28 (37%) | 37 (42%) |
| Middle | 35 (45%) | 34 (38%) |
| High | 14 (18%) | 18 (20%) |
| Statin use | 45 (58%) | 41 (46%) |
| HDL cholesterol (mg/dL) | 53.4 ± 18.2 | 66.3 ± 17.5 |
| LDL cholesterol (mg/dL)* | 112.9 ± 31.6 | 119.1 ± 36.3 |
| High sensitivity C reactive protein (mg/dL) | 0.12 ± 0.3 | 0.13 ± 0.3 |
| Glucose (mg/dL) | 106.1 ± 37.9 | 100 ± 29.5 |
| Myocardial infarction | 8 (10%) | 6 (7%) |
| COPD* | 10 (13%) | 2 (2%) |
| Asthma | 4 (5%) | 2 (2%) |
| Systolic blood pressure | 147.3 ± 18.2 | 142 ± 19.4 |
| Diastolic blood pressure | 90.6 ± 12.6 | 84.4 ± 11.6 |
| Telomere length | 1.04 ± 0.05 | 1.04 ± 0.04 |
| mtDNA content | 0.71 ± 0.04 | 0.78 ± 0.04 |
| Average annual PM2.5 (μg/m3) | 21.1 ± 1.72 | 21.1 ± 1.75 |
| Time at current residential address (years) | 35.9 ± 17.0 | 39.3 ± 16.8 |
Pearson correlation matrix between leukocyte telomere length, mtDNA content, the studied candidate genes, and annual PM2.5 exposure.
| Telomere length | mtDNA content | |||||||
|---|---|---|---|---|---|---|---|---|
| mtDNA content | 0.22** | |||||||
| 0.27** | 0.43*** | |||||||
| 0.05 | 0.04 | 0.20* | ||||||
| 0.22* | 0.26** | 0.74*** | 0.22* | |||||
| –0.20* | 0.02 | –0.11 | 0.12 | 0.03 | ||||
| –0.06 | –0.01 | 0.07 | 0.20* | 0.42*** | 0.40*** | |||
| –0.001 | 0.02 | –0.05 | 0.07 | 0.03 | 0.44*** | 0.24** | ||
| Annual PM2.5 exposure | –0.29*** | –0.40*** | –0.26** | 0.03 | –0.03 | 0.15 | 0.03 | 0.04 |
| * | ||||||||
Figure 1Relative percentage (%) difference in mitochondrial DNA content (n = 166), telomere length (T/S) ratio (n = 166), and SIRT1 expression (n = 125) in association with a 5-μg/m3 increment in average annual PM2.5 exposure adjusted for sex, age, BMI, socioeconomic status (based on education and monthly family income), statin use, past smoking status, white blood cell count, and percentage of neutrophils.
Associations between an IQR increase in average PM2.5 exposure during the previous year (long-term exposure) or during the previous month or week (short-term exposure) and log10-transformed telomere length (T/S ratio), mtDNA content, and SIRT1 expression.
| Exposure model | Telomere length | mtDNA content | ||||
|---|---|---|---|---|---|---|
| Estimated effect (95% CI) | Estimated effect (95% CI) | Estimated effect (95% CI) | ||||
| Single exposure | ||||||
| Last year | –0.040 (–0.065, 0.017) | 0.0005 | –0.065 (–0.094, –0.038) | 0.0001 | –0.041 (–0.077, –0.011) | 0.006 |
| Last month | 0.029 (0.017, 0.041) | 0.0001 | 0.038 (0.025, 0.050) | 0.0001 | 0.033 (0.015, 0.052) | 0.0005 |
| Last week | 0.003 (–0.007, 0.014) | 0.5 | 0.029 (0.09, 0.039) | 0.001 | 0.034 (0.016, 0.051) | 0.0003 |
| Multiple exposure | ||||||
| Last year | –0.032 (–0.053, –0.011) | 0.0031 | –0.055 (–0.074, –0.035) | 0.0001 | –0.039 (–0.066, –0.012) | 0.005 |
| Last month | 0.028 (0.015, 0.040) | 0.0001 | 0.023 (0.012, 0.04) | 0.0001 | 0.022 (0.002, 0.041) | 0.03 |
| Last week | –0.004 (–0.014, 0.006) | 0.4 | 0.022 (0.013, 0.032) | 0.0001 | 0.024 (0.005, 0.043) | 0.01 |
| IQR, interquartile range. | ||||||
Figure 2Correlation between (A) telomere length and SIRT1 expression, (B) mtDNA content and SIRT1 expression, and (C) mtDNA content and telomere length.
Figure 3Mediation analysis showing the estimated proportion of associations between PM2.5 (μg/m3) exposure and leukocyte mtDNA content and telomere length, mediated through SIRT1 expression if underlying assumptions of the analysis are valid.
Sensitivity analysis of the association between an IQR increase for past-year PM2.5 exposure (2.5 μg/m3) in annual average PM2.5 exposure and leukocyte log10-transformed telomere length (T/S ratio) and mtDNA content.
| Model variable | Telomere length | mtDNA content | ||
|---|---|---|---|---|
| Estimated effect (95% CI) | Estimated effect (95% CI) | |||
| Main model | –0.040 (–0.065, –0.017) | 0.0005 | –0.065 (–0.094, –0.038) | 0.0001 |
| + Glucose | –0.039 (–0.61, –0.017) | 0.0006 | –0.059 (–0.082, –0.037) | 0.0001 |
| + CRP | –0.034 (–0.057, –0.011) | 0.003 | –0.056 (–0.078, –0.034) | 0.0001 |
| + HDL | –0.032 (–0.054, –0.009) | 0.0057 | –0.057 (–0.080, –0.035) | 0.0001 |
| + LDL | –0.034 (–0.057, –0.011) | 0.0036 | –0.061 (–0.084, –0.038) | 0.0001 |
| + Systolic BP | –0.037 (–0.060, –0.014) | 0.0022 | –0.061 (–0.085, –0.037) | 0.0001 |
| + Diastolic BP | –0.037 (–0.061, –0.14) | 0.0022 | –0.061 (–0.085,–0.037) | 0.0001 |
| Excluding participants < 10 years at current address | –0.043 (–0.065, –0.021) | 0.0002 | –0.064 (–0.088, –0.041) | 0.0001 |
| The main model, adjusted for sex, age, BMI, socioeconomic status (based on education and monthly family income), statin use, past smoking status, white blood cell count, and percentage of neutrophils, was additionally adjusted for each listed covariate in a separate model. A separate sensitivity analysis was performed using the main model while excluding participants that lived < 10 years at their current address. | ||||